Division of Pulmonary and Critical Care, Washington University School of Medicine, St Louis, MO, USA.
Crit Care Med. 2012 Jul;40(7):2016-21. doi: 10.1097/CCM.0b013e318250aa72.
To identify the determinants of hospital mortality among patients with septic shock receiving appropriate initial antibiotic treatment.
A retrospective cohort study of hospitalized patients with blood culture positive septic shock (January 2002-December 2007).
Barnes-Jewish Hospital, a 1,250-bed urban teaching hospital.
Four hundred thirty-six consecutive patients with septic shock and a positive blood culture.
Data abstraction from computerized medical records.
Septic shock was associated with bloodstream infection due to Gram-negative bacteria (59.2%) and Gram-positive bacteria (40.8%). Two hundred twenty-four patients (51.4%) died during their hospitalization. The presence of infection attributed to antibiotic-resistant bacteria was similar for patients who survived and expired (22.6% vs. 20.1%; p = .516). Multivariate logistic regression analysis demonstrated that infection acquired in the intensive care unit (adjusted odds ratio 1.99; 95% confidence interval 1.52-2.60; p = .011) and increasing Acute Physiology and Chronic Health Evaluation II scores (one-point increments) (adjusted odds ratio 1.11; 95% confidence interval 1.09-1.14; p < .001) were independently associated with a greater risk of hospital mortality, whereas infection with methicillin-susceptible Staphylococcus aureus (adjusted odds ratio 0.32; 95% confidence interval 0.20-0.52; p = .017) was independently associated with a lower risk of hospital mortality. Patients infected with methicillin-susceptible Staphylococcus aureus infections were statistically younger and had lower Charlson comorbidity and Acute Physiology and Chronic Health Evaluation II scores compared to patients with non-methicillin-susceptible Staphylococcus aureus infections.
Among patients with septic shock who receive appropriate initial antibiotic treatment, acquisition of infection in the intensive care unit and severity of illness appear to be the most important determinants of clinical outcome.
确定接受适当初始抗生素治疗的脓毒症休克患者的医院死亡率的决定因素。
对 2002 年 1 月至 2007 年 12 月住院的血培养阳性脓毒症休克患者的回顾性队列研究。
巴恩斯-犹太医院,一家拥有 1250 张床位的城市教学医院。
436 例连续的脓毒症休克和血培养阳性患者。
从计算机化的病历中提取数据。
脓毒症休克与革兰氏阴性菌(59.2%)和革兰氏阳性菌(40.8%)引起的血流感染有关。224 名患者(51.4%)在住院期间死亡。存活和死亡患者的抗生素耐药菌感染的发生率相似(22.6%比 20.1%;p =.516)。多变量逻辑回归分析表明,重症监护病房获得的感染(调整优势比 1.99;95%置信区间 1.52-2.60;p =.011)和急性生理学和慢性健康评估 II 评分(每增加一分)(调整优势比 1.11;95%置信区间 1.09-1.14;p <.001)与更高的医院死亡率风险独立相关,而耐甲氧西林金黄色葡萄球菌感染(调整优势比 0.32;95%置信区间 0.20-0.52;p =.017)与更低的医院死亡率风险独立相关。感染耐甲氧西林金黄色葡萄球菌的患者在统计学上比感染非耐甲氧西林金黄色葡萄球菌的患者年龄更小,且合并症和急性生理学和慢性健康评估 II 评分更低。
在接受适当初始抗生素治疗的脓毒症休克患者中,重症监护病房获得的感染和疾病严重程度似乎是临床结局的最重要决定因素。